
AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
2026-08-10
0:00
13:40
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne
Artificial intelligence (AI) continues to generate excitement across oncology, but its real-world clinical impact remains inconsistent. In this episode of Exploring AI in Oncology, Dr. Ashish Manne, a Gastrointestinal Medical Oncologist at The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, shares his American Association for Cancer Research (AACR) presentation on AI-driven pathological subtyping in pancreatic cancer and highlights the critical shift that is moving AI from theoretical promise to practical application.
Fler avsnitt från "Oncology Data Advisor"



Missa inte ett avsnitt av “Oncology Data Advisor” och prenumerera på det i GetPodcast-appen.








